Consultant Clinical Geneticist, Dr Fiona Lalloo explains what it means to have Lynch Syndrome and how it can impact one's health. She also discusses what screening procedures are available for people with Lynch Syndrome in the UK.

For more information visit
https://www.bowelcanceruk.org.....uk/about-bowel-cance

Dr. Guillem discusses his article in JACS, "Risk of Metachronous Colorectal Neoplasm Following a Segmental Colectomy in Lynch Syndrome Patients According to MMR Gene Status." https://www.journalacs.org/art....icle/S1072-7515(20)3

For more information on genetic testing visit https://www.ambrygen.com/

Kory Jasperson, MS, CGC and Andrea Forman, MS, CGC will be discussing the benefits of paired tumor/germline testing for Lynch syndrome. This presentation will outline the clinical dilemma faced by clinicians when receiving discordant tumor screening and germline testing results for Lynch syndrome, review the current literature regarding somatic genetic testing after abnormal MSI/IHC results, and compare the utility of paired tumor/germline testing for Lynch syndrome to other testing strategies.

Presented by:
Laura Panos Smith
Kory Jasperson, MS,CGC
Andrea Forman

Learn about our dedicated Lynch Syndrome Center - https://www.dana-farber.org/lynchsyndrome Huma Rana, MD, clinical director of the Center for Cancer Genetics at Dana-Farber, and Lori Dobson, MS, CGC, genetic counseling coordinator at the Center for Fetal Medicine and Prenatal Genetics at Brigham and Women’s Hospital, describe the reproductive considerations and options families with Lynch syndrome face.

Learn about our dedicated Lynch Syndrome Center - https://www.dana-farber.org/lynchsyndrome
C. Richard Boland, MD, Professor of Medicine at the University of California San Diego, provides a rich history of his family’s unique role in the discovery of the hereditary colorectal cancer syndrome, Lynch syndrome.

Learn about our dedicated Lynch Syndrome Center - https://www.dana-farber.org/lynchsyndrome Sharon Goyette, captain of Team Lynch Syndrome, talks about the Jimmy Fund Walk team that survivors, patients, caregivers, and staff started in 2013, which has raised over $60,000 to support Lynch syndrome research, treatment, education, and patient advocacy at Dana-Farber Cancer Institute.